Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Natera, Inc. v. ArcherDX, Inc.
Case Number:
1:20-cv-00125
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 01, 2023
Natera Wins Cancer Test Injunction After $19M IP Verdict
A Delaware federal judge has barred Invitae Corp. from using its Personalized Cancer Monitoring test in certain ways that infringe patents owned by Natera Inc., according to a rare injunction made public Friday.
-
October 18, 2023
ArcherDX Renews Bid To Ax $19M Patent Verdict
ArcherDX wants a Delaware federal judge to throw out a jury finding that it owes $19.35 million in a patent infringement suit from Natera Inc. over patents covering cancer testing products, pointing to a recent case involving Google and Sonos.
-
September 05, 2023
Natera Cancer Test Patents Upheld In Wake Of $19M Verdict
A Delaware federal judge on Tuesday upheld a pair of Natera Inc. patents covering cancer testing products, rejecting competitor ArcherDX's argument that Natera waited too long before filing for patents and suing ArcherDX for infringement.
-
June 22, 2023
ArcherDX Says Natera Dragged Feet On Patent Filings
Genetic testing company Natera Inc. waited until competitor ArcherDX sunk millions into similar cancer testing products before filing for patents and suing ArcherDX for infringement, an "unreasonable" and "unexplained" delay that should bar them from enforcing two patents, ArcherDX argued in Delaware federal court Thursday.
-
June 15, 2023
IP Forecast: It's Deja Vu In $2.75B Cisco Patent Row
A small Virginia cybersecurity company will once again be making the case that Cisco is selling routers that infringe its software patents after a stock conflict sank the startup's $2.75 billion win. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
May 15, 2023
Natera Nets $19M Verdict In Cancer Test Patent Case
A Delaware federal jury on Monday found that a unit of genetic testing company Invitae owes about $19.35 million for directly infringing three Natera patents covering cancer testing technology.